1. Home
  2. LYRA vs NTRP Comparison

LYRA vs NTRP Comparison

Compare LYRA & NTRP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LYRA
  • NTRP
  • Stock Information
  • Founded
  • LYRA 2005
  • NTRP 1985
  • Country
  • LYRA United States
  • NTRP United States
  • Employees
  • LYRA N/A
  • NTRP N/A
  • Industry
  • LYRA Medical/Dental Instruments
  • NTRP
  • Sector
  • LYRA Health Care
  • NTRP
  • Exchange
  • LYRA Nasdaq
  • NTRP NYSE
  • Market Cap
  • LYRA 15.0M
  • NTRP 12.7M
  • IPO Year
  • LYRA 2020
  • NTRP N/A
  • Fundamental
  • Price
  • LYRA $9.40
  • NTRP $3.44
  • Analyst Decision
  • LYRA Buy
  • NTRP Hold
  • Analyst Count
  • LYRA 2
  • NTRP 1
  • Target Price
  • LYRA $16.00
  • NTRP $5.00
  • AVG Volume (30 Days)
  • LYRA 1.9M
  • NTRP 56.6K
  • Earning Date
  • LYRA 08-13-2025
  • NTRP 05-29-2025
  • Dividend Yield
  • LYRA N/A
  • NTRP N/A
  • EPS Growth
  • LYRA N/A
  • NTRP N/A
  • EPS
  • LYRA N/A
  • NTRP N/A
  • Revenue
  • LYRA $1,185,000.00
  • NTRP $501,422.00
  • Revenue This Year
  • LYRA N/A
  • NTRP $2,544.87
  • Revenue Next Year
  • LYRA $1,286.17
  • NTRP N/A
  • P/E Ratio
  • LYRA N/A
  • NTRP N/A
  • Revenue Growth
  • LYRA N/A
  • NTRP 9.30
  • 52 Week Low
  • LYRA $3.81
  • NTRP $1.39
  • 52 Week High
  • LYRA $37.50
  • NTRP $8.50
  • Technical
  • Relative Strength Index (RSI)
  • LYRA 45.31
  • NTRP 59.00
  • Support Level
  • LYRA $10.15
  • NTRP $3.00
  • Resistance Level
  • LYRA $14.88
  • NTRP $4.20
  • Average True Range (ATR)
  • LYRA 2.03
  • NTRP 0.49
  • MACD
  • LYRA -0.67
  • NTRP 0.02
  • Stochastic Oscillator
  • LYRA 0.42
  • NTRP 47.59

About LYRA Lyra Therapeutics Inc.

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

About NTRP NEXTTRIP INC

NextTrip Inc is a technology-driven platform delivering travel booking and travel media solutions. It provides individual and group travelers with vacations to popular and sought-after destinations in Mexico, the Caribbean, and across the world. NextTrip Media platform - Travel Magazine offers a social media platform for viewers to explore, educate, and share with friends their bucket list travel. The company is also launching an end-to-end content ecosystem that uses AI-assisted travel planning capturing advertising, building brand awareness, rewarding loyalty, and driving bookings.

Share on Social Networks: